Abstract
Information on cellular analysis of bronchoalveolar lavage (BAL) in patients with COVID-19 is limited. Some studies have described an increase in lymphocyte percentage or exuberant plasmacytosis. Some reports addressed the importance of molecular testing on BAL samples to confirm COVID-19 pneumonia, in clinically highly suspected patients with consecutive negative nasopharyngeal swab results. In addition to atypical lymphocytes in the peripheral blood, morphologic findings of atypical lymphocytes in BAL were also reported in a few patients. The objective of this study was to describe the cytopathic characteristics identified, any data presented here are descriptives and intended to trigger further research. Three general aspects have been evaluated in each sample: reactive changes, virus-related pathological changes, and differential leukocyte count. Seventeen samples were collected. All samples were negative for malignancy, with an inflammatory background, predominantly lymphohistiocytic in 5 samples, histiocytic in 9, and 3 with predominantly neutrophilic. Hemosiderin-laden macrophages were observed in 12/17. Nonspecific reactive cell changes were identified in 4 samples, including bronchial, alveolar, and reserve cell hyperplasia. Virus-related pathological changes were observed in 14 samples, such as loss of nuclear chromatin pattern, lymphocytes with atypical nuclei, nuclear and cytoplasmic inclusions, multinucleations in bronchial cells and macrophages, or multinucleated giant cells. The identification of multinucleated giant cells could represent a cytopathic effect induced by the virus, at the same time the nuclear clearance of pneumocytes as a possible direct effect. BAL is a procedure aimed at obtaining cells from the respiratory tract that can provide valuable and rapid information. It is important to collect and describe as many cytopathological findings as possible, which can provide relevant information for future studies.
References
1.
Lu
R
, Zhao
X
, Li
J
, Niu
P
, Yang
B
, Wu
H
, Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding
. Lancet
. 2020
;395
:565
–74
. .2.
Giani
M
, Seminati
D
, Lucchini
A
, Foti
G
, Pagni
F
. Exuberant plasmocytosis in bronchoalveolar lavage specimen of the first patient requiring extracorporeal membrane oxygenation for SARS-CoV-2 in Europe
. J Thorac Oncol
. 2020
;15
:e65
–6
. .3.
Liao
M
, Liu
Y
, Yuan
J
, Wen
Y
, Xu
G
, Zhao
J
, Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
. Nat Med
. 2020
;26
:842
–4
. .4.
Flandes
J
. The bronchoalveolar lavage: a simple procedure that provides much information
. J Respir Pathol
. 2011
;14
(2
):41
–2
.5.
Castellá
J
, Ancochea
J
, Llorente
JL
. Lavado broncoalveolar
. Recomendaciones SEPAR
. 2008
:79
–100
.6.
7.
Jara
J
, Martín
J
, Gómez
L
. Bronchoalveolar Lavage findings in patients with diffuse interstitial lung disease: prospective Study of a cohort of 562 patients
. Arch Bronconeumol
. 2009
;45
(3
):111
–7
.8.
Voiriot
G
, Fajac
A
, Lopinto
J
, Labbe
V
, Fartoukh
M
. Bronchoalveolar lavage findings in severe COVID-19 pneumonia
. Intern Emerg Med
. 2020 Oct
;15
(7
):1333
–4
.9.
Voiriot
G
, Fajac
A
, Gibelin
A
, Parrot
A
, Fartoukh
M
. Alveolar lymphocytosis with plasmacytosis in severe COVID-19
. Respir Med Res
. 2020
;78
:100784
. .10.
Hauge
MT
, Nilsen
E
, Nordseth
T
. Acute respiratory distress syndrome in a patient with COVID-19 and negative nasopharyngeal swabs
. Tidsskr Nor Laegeforen
. 2020
;140
:140
. .11.
Winichakoon
P
, Chaiwarith
R
, Liwsrisakun
C
, Salee
P
, Goonna
A
, Limsukon
A
, Negative nasopharyngeal and oropharyngeal swabs do not rule out COVID-19
. J Clin Microbiol
. 2020
;58
:58
. .12.
Woloshin
S
, Patel
N
, Kesselheim
AS
. False negative tests for SARS-CoV-2 infection: challenges and implications
. N Engl J Med
. 2020
;383
:e38
. .13.
Weinberg
SE
, Behdad
A
, Ji
P
. Atypical lymphocytes in peripheral blood of patients with COVID-19
. Br J Haematol
. 2020
;190
:36
. .14.
Berg
RMG
, Ronit
A
, Rørvig
SB
, Plovsing
RR
. Atypical lymphocytes in bronchoalveolar lavage fluid from patients with COVID-19 ARDS
. Pathol Res Pract
. 2020
;216
:153242
. .15.
Vergé
V
, Soufan
R
. COVID-19-induced atypical pulmonary lymphocytes
. Blood
. 2020
;136
:2241
. .16.
Gualano
G
, Musso
M
, Mosti
S
, Mencarini
P
, Mastrobattista
A
, Pareo
C
, Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: a case report
. Int J Infect Dis
. 2020
;97
:174
–6
. .17.
Baughman
RP
, Dohn
MN
, Loudon
RG
, Frame
PT
. Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections
. Chest
. 1991
;99
:92
–7
. .18.
Allaouchiche
B
, Jaumain
H
, Dumontet
C
, Motin
J
. Early diagnosis of ventilator-associated pneumonia. Is it possible to define a cutoff value of infected cells in BAL fluid?
Chest
. 1996
;110
:1558
–65
. .19.
Var
F
, Buitrago
AF
. Concordancia entre el gram y el cultivo del lavado broncoalveolar en pacientes con neumonía asociada al ventilador
. Bogotá
: CRAI. Universidad del Rosario
; 2010
.20.
Corrin
B
, Nicholson
A
. Pathology of the lungs
. 2nd ed. London
: Churchill Livingstone/Elsevier
; 2006
. p. 149
–72
.21.
Caramaschi
S
, Kapp
M
, Eisenberg
R
, Johnson
J
. Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review
. Mod Pathol
. 2021
;24
:1
–20
.22.
Buja
L
, Wolf
D
, Zhao
B
, Akkanti
B
, McDonald
M
, Lelenwa
L
, The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities
. Cardiovasc Pathol
. 2020
;48
:107233
–3
. .23.
Menter
T
, Haslbauer
JD
, Nienhold
R
, Savic
S
, Hopfer
H
, Deigendesch
N
, Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
. Histopathology
. 2020
;77
:198
–209
. .24.
Wichmann
D
, Sperhake
JP
, Lütgehetmann
M
, Steurer
S
, Edler
C
, Heinemann
A
, Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study
. Ann Intern Med
. 2020
;173
:268
–77
. .25.
Carsana
L
, Sonzogni
A
, Nasr
A
, Rossi
RS
, Pellegrinelli
A
, Zerbi
P
, Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
. Lancet Infect Dis
. 2020
;20
:1135
–40
. .26.
Edler
C
, Schröder
AS
, Aepfelbacher
M
, Fitzek
A
, Heinemann
A
, Heinrich
F
, Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany
. Int J Leg Med
. 2020
;134
(4
):1275
–84
. .27.
Lax
SF
, Skok
K
, Zechner
P
, Kessler
HH
, Kaufmann
N
, Koelblinger
C
, Pulmonary arterial thrombosis in COVID-19 with fatal outcome : results from a prospective, single-center, clinicopathologic case series
. Ann Intern Med
. 2020
;173
:350
–61
. .28.
Borczuk
AC
, Salvatore
SP
, Seshan
SV
, Patel
SS
, Bussel
JB
, Mostyka
M
, COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City
. Mod Pathol
. 2020
;33
:2156
–68
. .29.
Bradley
BT
, Maioli
H
, Johnston
R
, Chaudhry
I
, Fink
SL
, Xu
H
, Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series
. Lancet
. 2020
;396
:320
–32
. .30.
Tian
S
, Hu
W
, Niu
L
, Liu
H
, Xu
H
, Xiao
SY
. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer
. J Thorac Oncol
. 2020
;15
:700
–4
. .31.
Sauter
JL
, Baine
MK
, Butnor
KJ
, Buonocore
DJ
, Chang
JC
, Jungbluth
AA
, Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies
. Histopathology
. 2020
;77
:915
–25
. .32.
Yan
L
, Mir
M
, Sanchez
P
, Beg
M
, Peters
J
, Enriquez
O
, COVID-19 in a hispanic woman
. Arch Pathol Lab Med
. 2020
;144
:1041
–7
. .33.
Fitzek
A
, Sperhake
J
, Edler
C
, Schröder
AS
, Heinemann
A
, Heinrich
F
, Evidence for systematic autopsies in COVID-19 positive deceased: case report of the first German investigated COVID-19 death
. Rechtsmedizin
. 2020
:1
–6
. .34.
Autopsy Covid- Electronic address: [email protected]
. The first COVID-19 autopsy in Spain performed during the early stages of the pandemic
. Rev Esp Patol
. 2020
;53
:182
–7
. .35.
Pernazza
A
, Mancini
M
, Rullo
E
, Bassi
M
, De Giacomo
T
, Rocca
CD
, Early histologic findings of pulmonary SARS-CoV-2 infection detected in a surgical specimen
. Virchows Arch
. 2020
;477
:743
–8
. .36.
Zhang
H
, Zhou
CY
, Wei
P
, Yue
H
, Wang
R
, Hu
M
, Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19
. Ann Intern Med
. 2020
;172
:629
. .37.
Youd
E
, Moore
L
. COVID-19 autopsy in people who died in community settings: the first series
. J Clin Pathol
. 2020
;73
:840
–4
. .38.
Bösmüller
H
, Traxler
S
, Bitzer
M
, Häberle
H
, Raiser
W
, Nann
D
, The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation
. Virchows Arch
. 2020
;477
:349
–57
. .39.
Xu
Z
, Shi
L
, Wang
Y
, Zhang
J
, Huang
L
, Zhang
C
, Pathological findings of COVID-19 associated with acute respiratory distress syndrome
. Lancet Respir Med
. 2020
;8
:420
–2
. .40.
Tian
S
, Xiong
Y
, Liu
H
, Niu
L
, Guo
J
, Liao
M
, Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies
. Mod Pathol
. 2020
;33
:1007
–14
. .41.
Meyer
KC
. Bronchoalveolar lavage as a diagnostic tool
. Semin Respir Crit Care Med
. 2007
;28
:546
–60
. .42.
Meyer
KC
, Raghu
G
, Baughman
RP
, Brown
KK
, Costabel
U
, du Bois
RM
, An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease
. Am J Respir Crit Care Med
. 2012
;185
:1004
–14
. .43.
Bouros
D
, Nicholson
AC
, Polychronopoulos
V
, du Bois
RM
. Acute interstitial pneumonia
. Eur Respir J
. 2000
;15
:412
–8
. .44.
Juss
JK
, House
D
, Amour
A
, Begg
M
, Herre
J
, Storisteanu
DM
, Acute respiratory distress syndrome neutrophils have a distinct phenotype and are resistant to phosphoinositide 3-kinase inhibition
. Am J Respir Crit Care Med
. 2016
;194
(8
):961
–73
. .45.
Schutgens
RE
. D-dimer in COVID-19: a guide with pitfalls
. Hemasphere
. 2020
;4
:422
.46.
Padilla-Carlin
DJ
, Schladweiler
MCJ
, Shannahan
JH
, Kodavanti
UP
, Nyska
A
, Burgoon
LD
, Pulmonary inflammatory and fibrotic responses in Fischer 344 rats after intratracheal instillation exposure to Libby amphibole
. J Toxicol Environ Health A
. 2011
;74
:1111
–32
. .47.
Stadlmann
S
, Hein-Kuhnt
R
, Singer
G
. Viropathic multinuclear syncytial giant cells in bronchial fluid from a patient with COVID-19
. J Clin Pathol
. 2020
;73
:607
–8
. .48.
Grasselli
G
, Foti
G
, Patroniti
N
, Giuffrida
A
, Cortinovis
B
, Zanella
A
, A case of ARDS associated with influenza A: H1N1 infection treated with extracorporeal respiratory support
. Minerva Anestesiol
. 2009
;75
:741
–5
.49.
Pritt
BS
, Aubry
MC
. Histopathology of viral infections of the lung
. Semin Diagn Pathol
. 2017
;34
:510
–7
. .50.
Alsaad
KO
, Hajeer
AH
, Al Balwi
M
, Al Moaiqel
M
, Al Oudah
N
, Al Ajlan
A
, Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection: clinicopathological and ultrastructural study
. Histopathology
. 2018
;72
:516
–24
. .51.
Franks
TJ
, Chong
PY
, Chui
P
, Galvin
JR
, Lourens
RM
, Reid
AH
, Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore
. Hum Pathol
. 2003
;34
:743
–8
. .52.
Martines
RB
, Ritter
JM
, Matkovic
E
, Gary
J
, Bollweg
BC
, Bullock
H
, Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States
. Emerg Infect Dis
. 2020
;26
:2005
. .53.
Guilliams
M
, De Kleer
S
, Henri
H
, Post
S
, Vanhoutte
L
, De Prijck
S
, Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF
. J Exp Med
. 2013
;210
(10
):1977
–92
. .54.
Hashimoto
D
, Chow
A
, Noizat
C
, Teo
P
, Beasley
MB
, Leboeuf
M
, Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes
. Immunity
. 2013
;38
(4
):792
–804
. .55.
Divangahi
M
, King
I
, Pernet
E
. Alveolar macrophages and type I IFN in airway homeostasis and immunity
. Trends Immunol
. 2015
;36
(5
):307
–14
. .56.
Pribul
P
, Harker
J
, Wang
B
, Wang
H
, Tregoning
JS
, Schwarze
J
, Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development
. J Virol
. 2008
;82
(9
):4441
–8
. .57.
Kumagai
Y
, Takeuchi
O
, Kato
H
, Kumar
H
, Matsui
K
, Morii
E
, Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses
. Immunity
. 2007
;27
(2
):240
–52
. .58.
Hussell
T
, Bell
TJ
. Alveolar macrophages: plasticity in a tissue-specific context
. Nat Rev Immunol
. 2014
;14
:81
–93
. .59.
Goritzka
M
, Makris
S
, Kausar
F
, Durant
L
, Pereira
C
, Kumagai
Y
, Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes
. J Exp Med
. 2015
;212
(5
):699
–714
. .60.
Pagliaro
P
. Is macrophages heterogeneity important in determining COVID-19 lethality?
Med Hypotheses
. 2020
;143
:110073
. .61.
Merino
A
, Vlagea
A
, Molina
A
, Egri
N
, Laguna
J
, Barrera
K
, Atypical lymphoid cells circulating in blood in COVID-19 infection: morphology, immunophenotype and prognosis value
. J Clin Pathol
. 2020
.© 2022 S. Karger AG, Basel
2022
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
